Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 8/20 | 0.46 |
| ▸ | EPHB4 | P54760 | 3/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
| ▸ | KMO | O15229 | 1/20 | 0.38 |
| ▸ | FEN1 | P39748 | 1/20 | 0.36 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.36 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.36 |
| ▸ | MINK1 | Q8N4C8 | 1/20 | 0.36 |
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | NQO2 | P16083 | 1/20 | 0.34 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15638482 | 0.85 | TGFBR1 (0.66) | TGFBR1MAP4K4MINK1TNIK | |
| SCHEMBL30117779 | 0.85 | TGFBR1 (0.66) | TGFBR1MAP4K4MINK1TNIK | |
| SCHEMBL18703948 | 0.83 | TGFBR1 (0.47) | TGFBR1EPHB4ADORA2AADORA1KMO | |
| SCHEMBL15638166 | 0.82 | EPHB4 (0.48) | TGFBR1EPHB4ADORA2AADORA1KMO | |
| SCHEMBL15639583 | 0.78 | TGFBR1 (0.51) | TGFBR1ADORA2AADORA1KMOSUCNR1 | |
| SCHEMBL15638324 | 0.76 | TGFBR1 (0.43) | TGFBR1EPHB4ADORA2AADORA1KMO | |
| SCHEMBL15638112 | 0.76 | TGFBR1 (0.49) | TGFBR1ADORA2AADORA1KMOSUCNR1 | |
| SCHEMBL15638447 | 0.76 | ADORA2A (0.43) | TGFBR1EPHB4ADORA2AADORA1KMO | |
| SCHEMBL15638226 | 0.74 | ACVR1 (0.41) | TGFBR1KMOSUCNR1MAP4K4 | |
| SCHEMBL15638420 | 0.74 | TGFBR1 (0.62) | TGFBR1ADORA2AADORA1KMO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3129367-B1 | 2,3-DISUBSTITUTED PYRIDINE COMPOUNDS AS TGF-BETA INHIBITORS | RIGEL PHARMACEUTICALS INC (US) | 2019-09-04 | — | — | EP | disclosed |